✦ LIBER ✦

Safety and Tolerability of an Olmesartan Medoxomil-Based Regimen in Patients with Stage 1 Hypertension

✍ Scribed by Steven G. Chrysant MD

Book ID: 119930901
Publisher: Springer International Publishing AG
Year: 2010
Tongue: English
Weight: 149 KB
Volume: 30
Category: Article
ISSN: 1179-1918
DOI: 10.2165/11536560-000000000-00000

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of an Olmesartan Medoxomil–Based

Results of an Olmesartan Medoxomil–Based Treatment Regimen in Hypertensive Patients

✍ Suzanne Oparil; Steven G. Chrysant; Dean Kereiakes; Jianbo Xu; Kathleen J. Chava 📂 Article 📅 2008 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 466 KB

Efficacy and Tolerability of Olmesartan

Efficacy and Tolerability of Olmesartan Medoxomil in Patients with Mild to Moderate Essential Hypertension

✍ Vivencio Barrios, Alessandro Boccanelli, Silke Ewald, Xavier Girerd, Anthony Hea 📂 Article 📅 2007 🏛 Springer International Publishing AG 🌐 English ⚖ 147 KB

Treatment of stage 1 and stage 2 hyperte

Treatment of stage 1 and stage 2 hypertension (HTN) utilizing an olmesartan medoxomil (OM)-based treatment algorithm

✍ Joel Neutel; David Smith; Tonous Silfani; Yonghee Lee; Michael Weber 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 67 KB

Efficacy and Safety of a Stepped-Care Re

Efficacy and Safety of a Stepped-Care Regimen Using Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide in Patients with Moderate-to-Severe Hypertension

✍ Prof. Massimo Volpe, Cristina Miele, Uwe Haag 📂 Article 📅 2009 🏛 Springer International Publishing AG 🌐 English ⚖ 153 KB

Efficacy and Tolerability of Olmesartan

Efficacy and Tolerability of Olmesartan Medoxomil Combined with Amlodipine in Patients with Moderate to Severe Hypertension after Amlodipine Monotherapy

✍ Prof. Massimo Volpe, Peter Brommer, Uwe Haag, Cristina Miele 📂 Article 📅 2009 🏛 Springer International Publishing AG 🌐 English ⚖ 142 KB

Metabolic effects and safety of hydrochl

Metabolic effects and safety of hydrochlorothiazide (HCTZ) in combination with olmesartan medoxomil (OLM) in stage 2 systolic hypertension (HTN)

✍ Joseph Izzo; Joel Neutel; Robert Dubiel; Findlay Walker 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 117 KB